| Identification | Back Directory | [Name]
1-(5-O-Methoxytrityl-2-deoxy--D-xylofuranosyl)uracil | [CAS]
2072145-82-3 | [Synonyms]
1-(5-O-Methoxytrityl-2-deoxy--D-xylofuranosyl)uracil
1-(5-O-Methoxytrityl-2-deoxy-b-D-xylofuranosyl)uracil
1-(5-O-Methoxytrityl-2-deoxy-beta-D-xylofuranosyl)uracil | [Molecular Formula]
C29H28N2O6 | [MDL Number]
MFCD28975286 | [MOL File]
2072145-82-3.mol | [Molecular Weight]
500.54 |
| Hazard Information | Back Directory | [Uses]
1-(5-O-Methoxytrityl-2-deoxy-β-D-xylofuranosyl)uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|